A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer

NCT00083941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

BIOLOGICAL: TroVax
BIOLOGICAL: Interleukin-2

Sponsor

Oxford BioMedica

Collaborators

[object Object]
[object Object]